Search results
Results from the WOW.Com Content Network
2021: In March, the company announced it would acquire Five Prime Therapeutics and its lead candidate, bemarituzumab, for $1.9 billion. [93] [94] [95] In the same month, Amgen acquired Rodeo Therapeutics for $720 million. [96] [97] The FDA approved Amgen's Lumakras in May for treatment of patients with KRAS-G12C-mutated non-small cell lung ...
San Diego Business Journal; San Diego City Beat; San Diego Jewish Journal; San Diego Magazine; San Diego Reader; San Diego Union-Tribune (acquired by Tribune Publishing) Times of San Diego; Retail. Le Travel Store (closed) Mor Furniture; Petco; PriceSmart; Sports. BikeBandit; BMC USA; Competitor Group, Inc. Ellsworth Handcrafted Bicycles ...
The company’s name comes from the Italian word for “targeted” (Mirati). Mirati Therapeutics is traded on the Nasdaq [6] under the ticker symbol MRTX. [7] It joined the exchange in 2013. [8] In October 2023, Bristol Myers Squibb agreed to acquire the company in an all-cash deal worth $4.8 billion, and an additional $1 billion in milestone ...
For premium support please call: 800-290-4726 more ways to reach us
Prime operates 44 acute care hospitals in 14 states. [12] The hospital network has over 45,000 employees and physicians and more than 8,700 patient beds. [2] Prime Healthcare’s national corporate headquarters is located in Ontario, California. [12]
This file contains additional information, probably added from the digital camera or scanner used to create or digitize it. If the file has been modified from its original state, some details may not fully reflect the modified file.
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer.
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. [2]